MeiraGTx is a gene therapy development company founded in 2015 as a spin off from Kadmon Holdings (a NYSE listed $450 million biopharma company).
year invested
2018
Industry
Healthcare
News
Website
If you are an innovative company, we want to hear from you.
Back to Portfolio